SPDR MSCI Europe Health Care UCITS ETF (EPA: STW)
France
· Delayed Price · Currency is EUR | Assets | 849.32M |
| Expense Ratio | 0.18% |
| PE Ratio | 23.92 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -95.03% |
| Volume | 302 |
| Open | 244.95 |
| Previous Close | 246.45 |
| Day's Range | 244.95 - 248.25 |
| 52-Week Low | 189.40 |
| 52-Week High | 248.25 |
| Beta | 1.03 |
| Holdings | n/a |
| Inception Date | Dec 5, 2014 |
About STW
SPDR MSCI Europe Health Care UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors France S.A. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Health Care Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as SPDR ETFs - SPDR MSCI Europe Health Care UCITS ETF. SPDR MSCI Europe Health Care UCITS ETF was formed on March 15, 2001 and is domiciled in Ireland.
Performance
STW had a total return of -95.03% in the past year. Since the fund's inception, the average annual return has been -9.45%, including dividends.
Top 10 Holdings
| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/S | NOVO.B | 23.31% |
| AstraZeneca PLC | AZN | 13.30% |
| Roche Holding AG | ROG.SW | 12.32% |
| Novartis AG Registered Shares | NOVN.SW | 11.92% |
| Sanofi SA | SAN.PA | 6.35% |
| GSK plc | GSK | 4.35% |
| EssilorLuxottica Société anonyme | EL | 3.65% |
| Lonza Group Ltd | LONN.SW | 2.69% |
| Alcon Inc | ALC.SW | 2.56% |
| argenx SE | ARGX.BR | 1.64% |